MLchartDataset catalogue

CT-2106

Term · Oncology and biomedicine · MLC-T-ONC-002164

A form of the anticancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin.

Table 1. Record
IdentifierMLC-T-ONC-002164
FieldOncology and biomedicine
Expansionspolyglutamate camptothecin
ReferencesNCI Dictionary of Cancer Terms
Record as JSON 
{
  "id": "MLC-T-ONC-002164",
  "term": "CT-2106",
  "field": "Oncology and biomedicine",
  "definition": "A form of the anticancer drug camptothecin that may have fewer side effects and work better than camptothecin. It is being studied in the treatment of cancer. It is a type of DNA topoisomerase inhibitor. Also called polyglutamate camptothecin.",
  "expansions": [
    "polyglutamate camptothecin"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/ct-2106/"
}

Record 5,478 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.